ArticleBMC health services research2025
Gender equity and career progression among Croatian oncology professionals compared with the ESMO global survey.
Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBased on the 2016 and 2021 ESMO Women for Oncology (W4O) surveys, which revealed persistent gender disparities in oncology, we conducted a national survey to examine career-related challenges among oncology professionals in Croatia and compare them with international trends.
methodsWe administered an anonymous online survey adapted from the 2021 ESMO W4O questionnaire, contextualized for the Croatian setting. The survey explored the perceived impact of gender, political affiliation, religion, and sexual orientation on career development. Responses were analyzed by gender and age.
resultsA total of 206 participants responded (74% women, 26% men), primarily medical and radiation oncologists (55%), followed by pathologists (15%) and surgical oncologists (5%). Among all respondents, 41% were aged ≤ 40, 18% were residents, and 43% had worked in oncology for less than 10 years. Most worked in university (42%) or general hospitals (39%). Gender was reported to moderately or significantly affect career progression in 40% of cases—more frequently than political affiliation (22%)—while religion and sexual orientation had minimal influence. Major gender-related barriers included poor work–life balance (69%), societal pressure (46%), unconscious bias (44%), and limited leadership opportunities for women (33%). Workplace gender-based discrimination was reported by 36%, and 38% had experienced or witnessed harassment; however, only 11% reported incidents. Although 80% valued career advancement, 34% were dissatisfied with their progression. Overall, 86% faced career barriers, primarily poor work–life balance (56%), lack of mentors (42%), and demotivating work environments (36%). Administrative overload was widespread: 59% felt overwhelmed, and 61% worked more than 8 h daily.
conclusionsGender remains a substantial barrier to career advancement in oncology. Systemic interventions are needed to address work–life imbalance, discrimination, and structural burdens to support equity and sustainable career development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.